Latest News
There are many angles, companies, and strategies for investors to profit from the rise of driverless vehicles. Is Lucid actually a dark horse to become a big winner?
Via The Motley Fool · March 20, 2026
There's much to like about Manulife stock at a reasonable valuation and a nice and growing dividend.
Via The Motley Fool · March 20, 2026
Understand the difference between investing and gambling. Learn how price movements can mislead your financial decisions.
Via The Motley Fool · March 20, 2026
At current dividend levels, holding 258 shares of this ideal TFSA stock can generate $250 in quarterly income, equating to $1,000/year.
Via The Motley Fool · March 20, 2026
The cloud giant's valuation has become much more reasonable following a brutal sell-off, and its massive backlog suggests brighter days ahead.
Via The Motley Fool · March 20, 2026
This isn't an ideal time to be involved with the metal.
Via The Motley Fool · March 20, 2026
Could Carlisle Companies be the hidden gem you've been searching for? Join us as we explore its strengths, management, and financial outlook in this insightful episode!
Via The Motley Fool · March 20, 2026
See how your TFSA compares to the $109,000 benchmark and whether these three investments can help supercharge your portfolio to new levels.
Via The Motley Fool · March 20, 2026
When markets can’t pick a direction, “mis-priced attention” can create chances to buy great businesses before sentiment returns.
Via The Motley Fool · March 20, 2026
A very bullish analyst move added real zip to the insurer's equity.
Via The Motley Fool · March 20, 2026

This healthcare company delivers sterilization and lab testing services to global medical, pharmaceutical, and food industry clients.
Via The Motley Fool · March 20, 2026
Industrial stocks make a great hedge against tech's volatility; consider these two.
Via The Motley Fool · March 20, 2026
The government is using artificial intelligence (AI) to review requests for Medicare to cover treatments.
Via The Motley Fool · March 20, 2026
Via MarketBeat · March 20, 2026

This medical technology firm delivers integrated blood management solutions to healthcare providers and plasma centers worldwide.
Via The Motley Fool · March 20, 2026
Dividend stock investors are attracted to Target.
Via The Motley Fool · March 20, 2026
Businesses that are less correlated with macroeconomic performance tend to do relatively well during downturns.
Via The Motley Fool · March 20, 2026
The broad stock market sell-off is creating opportunities for long-term investors to buy undervalued stocks.
Via The Motley Fool · March 20, 2026
Micron's quarterly financial update stunned investors in the stock market.
Via The Motley Fool · March 20, 2026
Advertisers are likely to cut spending amid slowing macroeconomic growth.
Via The Motley Fool · March 20, 2026

Record revenue, a swelling backlog, and new AI initiatives are redefining this satellite-imagery player’s trajectory, today, March 20, 2026.
Via The Motley Fool · March 20, 2026
The Iran war is driving down the prices of precious metals.
Via The Motley Fool · March 20, 2026
Dell stock popped after a federal arrest rocked its biggest AI server rival.
Via The Motley Fool · March 20, 2026

Organon & Co. develops branded and biosimilar therapies with a focus on women’s health and specialty pharmaceuticals.
Via The Motley Fool · March 20, 2026
These artificial intelligence (AI) stocks look like bargains.
Via The Motley Fool · March 20, 2026